Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?

Archives of Dermatology

Volumn 144, Issue 6, 2008, Pages 783-785

  Lehman, Julia S ^a,b   Mueller, Kurt K ^a   Schraith, Daniel F ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DAPSONE; METHOTREXATE; PREDNISONE;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; CONCEPTION; FEMALE; HUMAN; INTRAPARTUM CARE; PATIENT SAFETY; PEMPHIGUS VULGARIS; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; DAPSONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FAMILY PLANNING SERVICES; FEMALE; FERTILIZATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PEMPHIGUS; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 45349097472     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.6.783     Document Type: Article

References (20)

1. Kalayciyan A, Engin B, Serdaroglu S, et al. A retrospective analysis of patients with pemphigus vulgaris associated with pregnancy. Br J Dermatol. 2002;147 (2):396-397.
2. Goldberg NS, DeFeo C, Kirshenbaum N. Pemphigus vulgaris and pregnancy: risk factors and recommendations. J Am Acad Dermatol. 1993;28(5, pt 2):877-879.
3. Ruach M, Ohel G, Rahav D, et al. Pemphigus vulgaris and pregnancy. Obstet Gynecol Surv. 1995;50(10):755-760.
4. Mimouni D, Nousari CH, Cummins DL, et al. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol. 2003;49(6):1059-1062.
5. Tope WD, Kamino H, Briggaman RA, et al. Neonatal pemphigus vulgaris in a child born to a woman in remission. J Am Acad Dermatol. 1993;29(3):480-485.
6. Armenti VT, Moritz MJ, Davison JM. Drug safety issue in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf. 1998; 19(3):219-232.
7. Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf. 1998; 19(5):389-410.
8. Terpstra H, de Jong MC, Klokke AH. In vivo bound pemphigus antibodies in a stillborn infant: passive intrauterine transfer of pemphigus vulgaris? Arch Dermatol. 1979;115(3):316-319.
9. Hup JM, Bruinsma RA, Boersma ER, et al. Neonatal pemphigus vulgaris: transplacental transmission of antibodies. Pediatr Dermatol. 1986;3(6):468-472.
10. Fainaru O, Mashiach R, Kupferminc M, et al. Pemphigus vulgaris in pregnancy: a case report and review of literature. Hum Reprod. 2000;15(5):1195-1197.
11. Piontek JO, Borberg H, Sollberg S, et al. Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange. Br J Dermatol. 2000;143(2):455-456.
12. Chowdhury MM, Natarajan S. Neonatal pemphigus vulgaris associated with mild oral pemphigus vulgaris in the mother during pregnancy. Br J Dermatol. 1998; 139(3):500-503.
13. Ross MG, Kane B, Frieder R, et al. Pemphigus in pregnancy: a reevaluation of fetal risk. Am J Obstet Gynecol. 1986;155(1):30-33.
14. Connell W, Miller A. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf. 1999;21(4):311-323.
15. Expert EBPG. European best practice guidelines for renal transplantation, section IV: long-term management of the transplant recipient, IV.10: pregnancy in renal transplant recipients. Nephrol Dial Transplant. 2002;17(suppl 4):50-55.
16. Wasserstrum N, Laros RK Jr. Transplacental transmission of pemphigus. JAMA. 1983;249(11):1480-1482.
17. Shieh S, Fang YV, Becker JL, et al. Pemphigus, pregnancy, and plasmapheresis. Cutis. 2004;73(5):327-329.
18. Moncada B, Kettelsen S, Hernandez-Moctezuma JL, et al. Neonatal pemphigus vulgaris: role of passively transferred pemphigus antibodies. Br J Dermatol. 1982; 106(4):465-467.
19. Campo-Voegeli A, Muniz F, Mascaro JM, et al. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris. Br J Dermatol. 2002;147(4):801-805.
20. Vaughan Jones SA, Hern S, Nelson-Piercy C, et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol. 1999;141(1):71-81.